CN104547772A - Traditional Chinese medicine for treating irritable bowel syndrome - Google Patents

Traditional Chinese medicine for treating irritable bowel syndrome Download PDF

Info

Publication number
CN104547772A
CN104547772A CN201510000766.4A CN201510000766A CN104547772A CN 104547772 A CN104547772 A CN 104547772A CN 201510000766 A CN201510000766 A CN 201510000766A CN 104547772 A CN104547772 A CN 104547772A
Authority
CN
China
Prior art keywords
radix
chinese medicine
rhizoma
bowel syndrome
irritable bowel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510000766.4A
Other languages
Chinese (zh)
Inventor
刘凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUOSHAN COUNTY HOSPITAL OF CHINESE MEDICINE
Original Assignee
HUOSHAN COUNTY HOSPITAL OF CHINESE MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUOSHAN COUNTY HOSPITAL OF CHINESE MEDICINE filed Critical HUOSHAN COUNTY HOSPITAL OF CHINESE MEDICINE
Priority to CN201510000766.4A priority Critical patent/CN104547772A/en
Publication of CN104547772A publication Critical patent/CN104547772A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine for treating an irritable bowel syndrome, which comprises the following raw material ingredients: 4-8g osmorhiza aristata, 18-22g rhizoma corydalis, 8-12g radix bupleuri, 28-32g malt, 18-22g fructus aurantii immaturus, 8-12g white hyacinth bean, 4-8g herb of gold stargrass, 28-32g boat-fruited sterculia seed, 18-22g bighead atractylodes rhizome, 1-5g toona flower, 18-22g fiveleaf gynostemma herb, 13-17g radix aucklandiae, 1-5g geum urbanum, 3-7g rhizoma decumbentis, 18-22g Chinese angelica and 18-22g roxburgh rose. The traditional Chinese medicine has effects of strengthening a spleen and a stomach, diminishing inflammation and alleviating pain, can effectively alleviate abdominal distention and abdominal pain of a patient and has an obvious curative effect and no toxic or side effects.

Description

One treats irritable bowel syndrome Chinese medicine
technical field:
The present invention relates generally to the field of Chinese medicines, particularly relates to one and treats irritable bowel syndrome Chinese medicine.
background technology:
Irritable bowel syndrome (IBS) is one group to be continued or interval outbreak, and to suffer from abdominal pain, abdominal distention, bowl evacuation habit and (or) stool change into clinical manifestation, and lack the function of intestinal canal disorder disease of gastrointestinal tract structure and biochemistry exception.
At present, onset of irritable bowel syndrome mechanism still imperfectly understands, because pathogenesis is complicated, effective Therapeutic Method is not had in modern medicine, now, clinical is main mainly with symptomatic treatment, and drug treatment can effectively be treated without any single medicine so far, can not meet the needs of extensive patients.And Chinese medicine is from organic conception, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, certainly, side effect is little, treatment cost economy, has good development prospect for curative effect.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, provides one to treat irritable bowel syndrome Chinese medicine.It can effectively alleviate the symptoms such as stomachache, abdominal distention, and good effect, has no side effect.
The present invention is achieved by the following technical solutions:
One treats irritable bowel syndrome Chinese medicine, it is characterized in that: the weight proportion between each raw material components is: Radix Osmorhizae Laxae 4-8, Rhizoma Corydalis 18-22, Radix Bupleuri 8-12, Fructus Hordei Germinatus 28-32, Fructus Aurantii Immaturus 18-22, Semen Lablab Album 8-12, Herba hypoxis aureae 4-8, Semen Sterculiae Lychnophorae 28-32, Rhizoma Atractylodis Macrocephalae 18-22, Ailanthus altissima flower 1-5, Herb Gynostemmae Pentaphylli 18-22, Radix Aucklandiae 13-17, bodhi fragrant 1-5, Radix et Rhizoma Thalictri 3-7, Radix Angelicae Sinensis 18-22, Fructus Rosae Normalis 18-22.
One treats irritable bowel syndrome Chinese medicine, it is characterized in that: the weight proportion between each raw material components is: Radix Osmorhizae Laxae 6, Rhizoma Corydalis 20, Radix Bupleuri 10, Fructus Hordei Germinatus 30, Fructus Aurantii Immaturus 20, Semen Lablab Album 10, Herba hypoxis aureae 6, Semen Sterculiae Lychnophorae 30, the Rhizoma Atractylodis Macrocephalae 20, Ailanthus altissima spend 3, Herb Gynostemmae Pentaphylli 20, the Radix Aucklandiae 15, bodhi perfume (or spice) 3, Radix et Rhizoma Thalictri 5, Radix Angelicae Sinensis 20, Fructus Rosae Normalis 20.
Advantage of the present invention is:
Chinese medicine of the present invention has effect of invigorating the spleen and regulating the stomach, anti-inflammatory analgetic, can the effectively abdominal distention of reduction of patient and stomachache, and curative effect is obvious, has no side effect.
detailed description of the invention:
One treats irritable bowel syndrome Chinese medicine, and the weight (g) between each raw material components is: Radix Osmorhizae Laxae 6, Rhizoma Corydalis 20, Radix Bupleuri 10, Fructus Hordei Germinatus 30, Fructus Aurantii Immaturus 20, Semen Lablab Album 10, Herba hypoxis aureae 6, Semen Sterculiae Lychnophorae 30, the Rhizoma Atractylodis Macrocephalae 20, Ailanthus altissima spend 3, Herb Gynostemmae Pentaphylli 20, the Radix Aucklandiae 15, bodhi perfume (or spice) 3, Radix et Rhizoma Thalictri 5, Radix Angelicae Sinensis 20, Fructus Rosae Normalis 20.
Take above raw material components, medicine-feeding grinds that to add equivalent Mel be ball into powder, and each 10g, 3 times on the one, warm water delivery service, a course for the treatment of of January, takes three courses for the treatment of altogether.
For proving that the present invention has good curative effect, enumerate model case as follows:
1. Wang, man, 50 years old, Recurrent Abdominal Pain was suffered from diarrhoea 10 years, companion's Mucous Stool, and tenesmus, repeatedly colonoscopy no abnormality seen are evident in efficacy after treating a course for the treatment of with we, follow up a case by regular visits to 1 year without recurrence
2. Zhang, female, 38 years old, abdominal distention 5 years repeatedly, rare when doing during companion stool, colonoscopy was normal, and biochemical analysis is normal, and abdominal ultrasonic is normal, evident in efficacy after treating two courses for the treatment of with we, follows up a case by regular visits to 2 years without recurrence.
3. Liu, man, 48 years old, repeatedly defecate slightly dry, awareness of defecation is frequent, and colonoscopy is normal, and routine examination is normal, treats Be very effective after a course for the treatment of with we, follow up a case by regular visits to 2 years normal.
4 Dong, man, 58 years old, Mucous Stool companion tenesmus repeatedly, colonoscopy was normal, treats Be very effective after two courses for the treatment of, follow up a case by regular visits to 2 years without recurrence with we.。
5 thank certain, female, 60 years old, and Recurrent Abdominal Pain is suffered from diarrhoea 15 years, companion's Mucous Stool, and repeatedly colonoscopy is normal, treat Be very effective after two courses for the treatment of, follow up a case by regular visits to 3 years without recurrence with we.

Claims (2)

1. treat an irritable bowel syndrome Chinese medicine, it is characterized in that: the weight proportion between each raw material components is: Radix Osmorhizae Laxae 4-8, Rhizoma Corydalis 18-22, Radix Bupleuri 8-12, Fructus Hordei Germinatus 28-32, Fructus Aurantii Immaturus 18-22, Semen Lablab Album 8-12, Herba hypoxis aureae 4-8, Semen Sterculiae Lychnophorae 28-32, Rhizoma Atractylodis Macrocephalae 18-22, Ailanthus altissima flower 1-5, Herb Gynostemmae Pentaphylli 18-22, Radix Aucklandiae 13-17, bodhi fragrant 1-5, Radix et Rhizoma Thalictri 3-7, Radix Angelicae Sinensis 18-22, Fructus Rosae Normalis 18-22.
2. one according to claim 1 treats irritable bowel syndrome Chinese medicine, it is characterized in that: the weight proportion between each raw material components is: Radix Osmorhizae Laxae 6, Rhizoma Corydalis 20, Radix Bupleuri 10, Fructus Hordei Germinatus 30, Fructus Aurantii Immaturus 20, Semen Lablab Album 10, Herba hypoxis aureae 6, Semen Sterculiae Lychnophorae 30, the Rhizoma Atractylodis Macrocephalae 20, Ailanthus altissima spend 3, Herb Gynostemmae Pentaphylli 20, the Radix Aucklandiae 15, bodhi perfume (or spice) 3, Radix et Rhizoma Thalictri 5, Radix Angelicae Sinensis 20, Fructus Rosae Normalis 20.
CN201510000766.4A 2015-01-04 2015-01-04 Traditional Chinese medicine for treating irritable bowel syndrome Pending CN104547772A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510000766.4A CN104547772A (en) 2015-01-04 2015-01-04 Traditional Chinese medicine for treating irritable bowel syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510000766.4A CN104547772A (en) 2015-01-04 2015-01-04 Traditional Chinese medicine for treating irritable bowel syndrome

Publications (1)

Publication Number Publication Date
CN104547772A true CN104547772A (en) 2015-04-29

Family

ID=53065543

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510000766.4A Pending CN104547772A (en) 2015-01-04 2015-01-04 Traditional Chinese medicine for treating irritable bowel syndrome

Country Status (1)

Country Link
CN (1) CN104547772A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105727089A (en) * 2016-04-01 2016-07-06 广州暨南生物医药研究开发基地有限公司 Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103720844A (en) * 2012-10-11 2014-04-16 戴秀芳 Traditional Chinese medicine composition used for treating irritable bowel syndrome
CN103893329A (en) * 2012-12-26 2014-07-02 谭建 Pharmaceutical composition for treating irritable bowel syndrome
CN104013708A (en) * 2014-06-16 2014-09-03 罗京艺 Traditional Chinese medicine composition for oral administration to treat irritable bowel syndrome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103720844A (en) * 2012-10-11 2014-04-16 戴秀芳 Traditional Chinese medicine composition used for treating irritable bowel syndrome
CN103893329A (en) * 2012-12-26 2014-07-02 谭建 Pharmaceutical composition for treating irritable bowel syndrome
CN104013708A (en) * 2014-06-16 2014-09-03 罗京艺 Traditional Chinese medicine composition for oral administration to treat irritable bowel syndrome

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105727089A (en) * 2016-04-01 2016-07-06 广州暨南生物医药研究开发基地有限公司 Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome

Similar Documents

Publication Publication Date Title
Lee et al. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
CN103263615B (en) Traditional Chinese medicine preparation for treating stomach illness, enteritis and cholecystitis and preparation method thereof
CN104162124A (en) Traditional Chinese medicine for treating ulcerative colitis
CN102423478B (en) Pharmaceutical composition for treating chronic endometritis
CN103301439B (en) Traditional Chinese medicine composition for treating chronic enteritis and preparation method thereof
Meng et al. From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment
CN101347601A (en) Chinese medicine for treating gynecology disease and preparation method thereof
CN101623458A (en) Chinese medicament preparation for clearing away heat and promoting diuresis, and removing damp and toxin and preparation method thereof
CN103536742A (en) Pharmaceutical composition for treating chronic gastroenteritis and preparation method thereof
CN101850094B (en) Chinese medicinal adhesive plaster
CN103816415A (en) Traditional Chinese medicinal composition for treating habitual constipation
CN104547772A (en) Traditional Chinese medicine for treating irritable bowel syndrome
CN101664541B (en) Medicament for treating dysmenorrhoea and preparation method thereof
CN102552729B (en) Medicament for treating mesangial proliferative glomerulonephritis
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN104998054B (en) A kind of Chinese materia medica preparation for treating constipation of slow-remove type
CN103933505A (en) Traditional Chinese medicine for treating chronic nonspecific ulcerative colitis
CN103768327B (en) A kind of pure component Chinese medicine preparation and preparation technology treating functional dyspepsia
CN102920942A (en) Medicine for treating acute toothache
CN105521116A (en) Traditional Chinese medicine for treating bacillary dysentery
CN101062364B (en) Medicine for treating canine distemper disease
CN101411810B (en) Medicament for treating multiple sclerosis symptoms
CN101347602A (en) Method for treating gynecology inflammation
Zhang et al. Progress in the treatment of chronic glomerulonephritis with traditional Chinese medicine
CN103656323A (en) Traditional Chinese medicine for treating erythroderma-type psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150429

RJ01 Rejection of invention patent application after publication